Effect of Sapindus trifoliatus on hyperalgesic in vivo migraine models

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 3, 2005, Pages 469-475

  Arulmozhi, D K ^a,b   Veeranjaneyulu, A ^a   Bodhankar, S L ^b   Arora, S K ^a  

^a New Chemical Entity Research   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Dopamine; Hyperalgesia; Migraine; Morphine withdrawal; Sapindus trifoliatus

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; APOMORPHINE; DOPAMINE 2 RECEPTOR; HERBACEOUS AGENT; MORPHINE; RADIOLIGAND; SAPINDUS TRIFOLIATUS EXTRACT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLIMBING; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HOT PLATE TEST; HYPERALGESIA; IN VIVO STUDY; LIGAND BINDING; MALE; MIGRAINE; MOUSE; MOUSE STRAIN; NONHUMAN; SAPINDACEAE; SAPINDUS TRIFOLIATUS; STOMACH OBSTRUCTION; THERMAL STIMULATION; TREATMENT OUTCOME; WITHDRAWAL REFLEX;

ANIMALIA; SAPINDACEAE; SAPINDUS TRIFOLIATUS;

EID: 16844368168     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000300019     Document Type: Article

References (31)

1. Breslau N & Rasmussen BK (2001). The impact of migraine: epidemiology, risk factors and co-morbidities. Neurology, 56 (Suppl 1): 4-12.
2. 1-like receptor agonist in isolated dog saphenous vein. British Journal of Pharmacology, 94: 1123-1132.
3. Humphrey PPA, Feniuk W & Perren MJ (1990). Antimigraine drugs in development: Advances in serotonin receptor pharmacology. Headache 30 (Suppl 1): 12-16.
4. Amrey WK (1983). Flunarizine, calcium channel blocker: a new prophylactic drug in migraine. Headache, 23: 70-74.
5. Rogers KL, Grice ID & Griffiths LR (2000). Inhibition of platelet aggregation and 5-HT release by extracts of Australian plants used traditionally as headache treatments. European Journal of Pharmaceutical Sciences, 9: 355-363.
6. Gupta DR & Ahmed B (1990). Emarginatosides B and C: Two new saponins from Sapindus emarginatus fruits. Indian Journal of Chemistry, 29B: 268-270.
7. Kanchanapoom T, Kasai R & Yamasaki K (2001). Acetylated triterpene saponins from the Thai medicinal plant Sapindus emarginatus. Chemical and Pharmaceutical Bulletin, 49: 1195-1197.
8. Kritikar KR & Basu BD (1999). Indian Medicinal Plants. Vol. 1. International Book Distributors, New Delhi, India, 632-635.
9. Jain NK & Kulkarni SK (1999). Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. Journal of Ethnopharmacology, 6: 251-259.
10. Galeotti N, Ghelardini C, Grazioli I & Uslenghi C (2002). Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine. Pharmacological Research, 46: 245-250.
11. Ghelardini C, Galeotti N, Donaldson S & Bartolini A (1998). The antimigraine drug ergotamine is endowed with antihyperalgesic activity. Phytotherapy Research, 12: S10-S12.
12. Koster R, Anderson M & De Beer EJ (1975). Acetic acid analgesic screening. Federation Proceedings, 18: 412-413.
13. Chung IW, Moore NA, Kang UG & Kim YS (2002). Behavioral pharmacology of polygalasaponins indicates potential antipsychotic efficacy. Pharmacology, Biochemistry and Behavior, 71: 191-195.
14. Bylund DB & Toews ML (1993). Radioligand binding methods: practical guide and tips. American Journal of Physiology, 265: L421-L429.
15. Bylund DB & Murrin LC (2000). Radioligand saturation binding experiments over large concentration ranges. Life Sciences, 67: 2897-2911.
16. Zhu M, Bowery NG, Greengrass DM & Phillipson JD (1996). Application of radioligand receptor binding assays in the search for CNS active principles from Chinese medicinal plants. Journal of Ethnopharmacology, 54: 153-164.
17. Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL & Arora SK (2004). Investigations into the antinociceptive activity of Sapindus trifoliatus in various pain models. Journal of Pharmacy and Pharmacology, 56: 655-661.
18. Goadsby PJ, Edvinsson L & Ekman R (1990). Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminal system. Annals of Neurology 23: 193-196.
19. Moskowitz MA & Cutrer FM (1997). Attacking migraine headache from beginning to end. Neurology, 49: 1193-1195.
20. May A, Shepheard SL, Knorr M, Effert R, Wessing A, Hargreaves RJ, Goadsby PJ & Diener HC (1998). Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine. Brain, 121: 1231-1237.
21. Ghelardini C, Galeotti N, Donaldson S, Nicolodi M, Sicuteri F & Bartolini A (1996). Prevention by sumatriptan of hyperalgesia induced by morphine withdrawal. Fundamental and Clinical Pharmacology, 10: 192 (Abstract).
22. Ghelardini C, Galeotti N, Fignini M, Imperato A, Nicolodi M, Sicuteri F, Gessa GL & Bartoloni A (1996). The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. Journal of Pharmacology and Experimental Therapeutics, 279: 884-890.
23. Jones J, Sklar D, Dougherty J & White W (1989). Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. Journal of the American Medical Association, 261: 1174-1176.
24. Cuppola M, Yealy DM & Leibold RA (1986). Randomized placebo-controlled evaluation of prochlorperazine versus metoclopromide for emergency treatment of migraine headache. Annals of Emergency Medicine, 26: 541-546.
25. Peroutka SJ (1997). Dopamine and migraine. Neurology, 49: 650-656.
26. Ophoff RA, Van den Maagdenberg AM, Roon KI, Ferrari MD & Frantus RR (2001). The impact of pharmacogenetics for migraine. European Journal of Pharmacology, 9: 1-10.
27. Cerbo R, Barbanti P, Bizzi MG, Fabbrini G, Brusa L, Roberti C, Zanette E & Lenzi GL (1997). Dopamine hypersensitivity in migraine: role of the apomorphine test. Clinical Neuropharmacology, 20: 36-41.
28. Moore WA & Axton MS (1990). The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia. European Journal of Pharmacology, 178: 195-201.
29. 1-dopamine receptors. European Journal of Pharmacology, 148: 221-229.
30. Wagner H, Ott S, Jurcic K, Morton J & Neszmelyi A (1983). Chemistry, 12C NMR study and pharmacology of two saponins from Colubrina asiatica. Planta Medica, 48: 136-141.
31. Dubios MA, Ilyas M & Wagner H (1986). Cussnosides A and B, two triterpene saponins from Cussonia barteri. Planta Medica, 56: 80-83